Back to results
US 2020/0369676 A1Published application
Heterocyclic compound, application thereof and pharmaceutical composition comprising same
AssigneeSuzhou Sinovent Pharmaceuticals Co., Ltd.
InventorsYonghan HU, Dongdong WU, Wei PENG, Xin LI, Fan HU, Bin HUANG, Jinlian ZHU, Yuchuan WU
Life of this patent
Estimating the term…
Abstract
Disclosed in the present invention are a heterocyclic compound, an application thereof and a pharmaceutical composition comprising the same. Provided by the present invention are a heterocyclic compound represented by formula I or a pharmaceutically acceptable salt thereof. The compound has a novel structure and a good inhibitory activity against autotaxin (ATX).
Claims27
A heterocyclic compound of formula I or a pharmaceutically acceptable salt thereof, wherein,
- R1 is hydrogen, cyano, halogen, C1-C4 alkyl, halogen-substituted C1-C4 alkyl, C1-C4 alkoxy, or halogen-substituted C1-C4 alkoxy;
- m is 0, 1, 2, or 3, and R3 is independently selected from halogen, cyano, R3-1-substituted or unsubstituted C1-C4 alkyl, and R3-2-substituted or unsubstituted C1-C4 alkoxy;
- R3-1 and R3-2 are each independently selected from halogens;
- W1 is ═CH— or ═N—;
- W2 is ═CR4— or ═N—;
- W3 is —O—, —S—, —NH—, —N═CH—, —CH═N—, or —CH═CH—;
- when W2 is ═N—, R2 is hydrogen, cyano, halogen, R2-1-substituted or unsubstituted C1-C4 alkyl, —C(═O)CH3, —C(═O)CF3, —C(═O)OCH3, —C(═O)NH2, or —NHC(═O)CH3;
- R2-1 is independently selected from hydroxy and cyano;
- when W2 is ═CR4—, one of R2 and R4 is hydrogen, cyano, halogen, R2-2-substituted or unsubstituted C1-C4 alkyl, —C(═O)CH3, —C(═O)CF3, —C(═O)OCH3, —C(═O)NH2, or —NHC(═O)CH3, and the other one is hydrogen or C1-C4 alkyl;
- R2-2 is independently selected from hydroxy and cyano;
- R5 is halogen-substituted C1-C4 alkyl or C1-C4 alkyl;
- ring A is
- R6-1, R6-2, R6-3, R6-4, R6-5, R6-6, R6-7, R6-8, R6-9, R6-10, R6-11, R6-12, R6-13, R6-14, R6-15R6-16, R6-17, and R6-18 are each independently selected from hydrogen, R6-1-1 substituted or unsubstituted C1-C4 alkyl, and C3-C6 cycloalkyl;
- R6-1-1 is independently selected from hydroxy, cyano, halogen, and —C(═O)NH2;
- R7-1, R7-2, R7-3, R7-4, R7-5, R7-6, R7-7, R7-8, R7-9, R7-10, and R7-11 are each independently selected from hydrogen, cyano, halogen, C1-C4 alkyl, and halogen-substituted C1-C4 alkyl;
- R8-1, R8-2, R8-3, R8-4, R8-5, R8-6, R8-7, R8-8, R8-9, R8-10, R8-11, R8-12, R8-13, R8-14, and R8-15 are each independently selected from hydrogen, cyano, halogen, C1-C4 alkyl, and halogen-substituted C1-C4 alkyl;
- R11-1 is hydrogen or halogen;
- R11-2 is hydrogen, C1-C4 alkyl, or halogen-substituted C1-C4 alkyl;
- ring B is a C3-C10 cycloalky, a C4-C7 cycloalkenyl, a “4-10 membered monocyclic or bicyclic heterocycloalkyl having 1-3 heteroatoms selected from one or more of O, N, and S”, or a “4-7 membered heterocycloalkenyl having 1 double bond and 1-3 heteroatoms selected from one or more of O, N, and S”;
- R9 is -L1-L2-L3;
- L1 is a single bond or C1-C4 alkylene;
- L2 is —O—, —C(═O)—, —C(═O)O—, —OC(═O)—, —C(═O)—CH2—, —C(═O)—C(═O)—, —C(═O)—C(═O)NRL-1—, —NRL-2—, —C(═O)NRL-3—, —NRL-4C(═O)—, —NRL-5C(O) SO2—, —SO2NRL-6—, or —NRL-7SO2—;
- RL-1, RL-2, RL-3, RL-4, RL-5, RL-6, and RL-7 are each independently selected from hydrogen and C1-C4 alkyl;
- L3 is hydrogen, cyano, RL-8-substituted or unsubstituted C1-C4 alkyl, amino-substituted or unsubstituted C3-C7 cycloalkyl, RL-9-substituted or unsubstituted “4-10 membered monocyclic, bicyclic, or spirocyclic heterocycloalkyl having 1-3 heteroatoms selected from one or more of O, N and S”, RL-10-substituted or unsubstituted “5-6 membered heterocycloalkenyl having 1 double bond and 1-3 heteroatoms selected from one or more of O, N, and S”, or, RL-11-substituted or unsubstituted“5-6 membered heteroaryl having 1-3 heteroatoms selected from one or more of O, N, and S”;
- RL-8 is independently selected from hydroxy, cyano, halogen, and phenyl;
- RL-9 is independently selected from oxo, hydroxy, cyano, halogen, phenyl, C1-C4 alkyl, hydroxy-substituted C1-C4 alkyl, —SO2CH3, —C(═O)RL-9-1, and —NRL-9-2C(═O)RL-9-3;
- RL-9-1 is independently selected from C1-C4 alkyl and C1-C4 alkoxy;
- RL-9-2 is independently selected from hydrogen and C1-C4 alkyl;
- RL-9-3 is independently selected from C1-C4 alkyl;
- RL-10 is independently selected from oxo, hydroxy, cyano, halogen, phenyl, —SO2CH3, —C(═O)RL-10-1, and —NRL-10-2(═O)RL-10-3;
- RL-10-1 is independently selected from C1-C4 alkyl and C1-C4 alkoxy;
- RL-10-2 is independently selected from hydrogen and C1-C4 alkyl;
- RL-10-3 is independently selected from C1-C4 alkyl;
- RL-11 is independently selected from hydroxy, cyano, halogen, phenyl, —SO2CH3, —C(═O)RL-11-1, and —NRL-11-2C(═O)RL-11-3;
- RL-11-1 is independently selected from C1-C4 alkyl and C1-C4 alkoxy;
- RL-11-2 is independently selected from hydrogen and C1-C4 alkyl;
- RL-11-3 is independently selected from C1-C4 alkyl;
- and
- n is 0, 1, 2, 3, or 4, R10 is independently selected from hydroxy, halogen, oxo, and R10-1-substituted or unsubstituted C1-C4 alkyl;
- and
- R10-1 is independently selected from halogen, hydroxy, and C1-C4 alkoxy.
38 more elements
(canceled)
(canceled)
(canceled)
(canceled)
Dependencies are inferred from the claim text.